Cargando…
Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen
BACKGROUND: Antibodies constitute a powerful tool to study protein function, protein localization and protein-protein interactions, as well as for diagnostic and therapeutic purposes. High-throughput antibody development requires faster methodologies with lower antigen consumption. RESULTS: Here, we...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125328/ https://www.ncbi.nlm.nih.gov/pubmed/21635725 http://dx.doi.org/10.1186/1472-6750-11-61 |
_version_ | 1782207208008712192 |
---|---|
author | Babel, Ingrid Barderas, Rodrigo Peláez-García, Alberto Casal, J Ignacio |
author_facet | Babel, Ingrid Barderas, Rodrigo Peláez-García, Alberto Casal, J Ignacio |
author_sort | Babel, Ingrid |
collection | PubMed |
description | BACKGROUND: Antibodies constitute a powerful tool to study protein function, protein localization and protein-protein interactions, as well as for diagnostic and therapeutic purposes. High-throughput antibody development requires faster methodologies with lower antigen consumption. RESULTS: Here, we describe a novel methodology to select human monoclonal recombinant antibodies by combining in vitro protein expression, phage display antibody libraries and antibody microarrays. The application of this combination of methodologies permitted us to generate human single-chain variable fragments (scFvs) against two proteins: green fluorescent protein (GFP) and thioredoxin (Trx) in a short time, using as low as 5 μg of purified protein. These scFvs showed specific reactivity against their respective targets and worked well by ELISA and western blot. The scFvs were able to recognise as low as 31 ng of protein of their respective targets by western blot. CONCLUSION: This work describes a novel and miniaturized methodology to obtain human monoclonal recombinant antibodies against any target in a shorter time than other methodologies using only 5 μg of protein. The protocol could be easily adapted to a high-throughput procedure for antibody production. |
format | Online Article Text |
id | pubmed-3125328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31253282011-06-29 Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen Babel, Ingrid Barderas, Rodrigo Peláez-García, Alberto Casal, J Ignacio BMC Biotechnol Research Article BACKGROUND: Antibodies constitute a powerful tool to study protein function, protein localization and protein-protein interactions, as well as for diagnostic and therapeutic purposes. High-throughput antibody development requires faster methodologies with lower antigen consumption. RESULTS: Here, we describe a novel methodology to select human monoclonal recombinant antibodies by combining in vitro protein expression, phage display antibody libraries and antibody microarrays. The application of this combination of methodologies permitted us to generate human single-chain variable fragments (scFvs) against two proteins: green fluorescent protein (GFP) and thioredoxin (Trx) in a short time, using as low as 5 μg of purified protein. These scFvs showed specific reactivity against their respective targets and worked well by ELISA and western blot. The scFvs were able to recognise as low as 31 ng of protein of their respective targets by western blot. CONCLUSION: This work describes a novel and miniaturized methodology to obtain human monoclonal recombinant antibodies against any target in a shorter time than other methodologies using only 5 μg of protein. The protocol could be easily adapted to a high-throughput procedure for antibody production. BioMed Central 2011-06-02 /pmc/articles/PMC3125328/ /pubmed/21635725 http://dx.doi.org/10.1186/1472-6750-11-61 Text en Copyright ©2011 Babel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Babel, Ingrid Barderas, Rodrigo Peláez-García, Alberto Casal, J Ignacio Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen |
title | Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen |
title_full | Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen |
title_fullStr | Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen |
title_full_unstemmed | Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen |
title_short | Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen |
title_sort | antibodies on demand: a fast method for the production of human scfvs with minimal amounts of antigen |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125328/ https://www.ncbi.nlm.nih.gov/pubmed/21635725 http://dx.doi.org/10.1186/1472-6750-11-61 |
work_keys_str_mv | AT babelingrid antibodiesondemandafastmethodfortheproductionofhumanscfvswithminimalamountsofantigen AT barderasrodrigo antibodiesondemandafastmethodfortheproductionofhumanscfvswithminimalamountsofantigen AT pelaezgarciaalberto antibodiesondemandafastmethodfortheproductionofhumanscfvswithminimalamountsofantigen AT casaljignacio antibodiesondemandafastmethodfortheproductionofhumanscfvswithminimalamountsofantigen |